Bristol-Myers Squibb Co. (BMY)

Trade BMY now with
1/4/2019 3:23:41 PM Candel Therapeutics Completes $28.7 Mln Series B Financing
1/3/2019 6:59:44 AM Bristol-Myers Squibb Provides 2019 GAAP EPS View Range At $3.75 To $3.85 And Non-GAAP EPS View Range At $4.10 To $4.20
1/3/2019 6:59:00 AM Bristol-Myers Squibb To Acquire Celgene In Cash, Stock Transaction With Equity Value Of $74 Bln
12/19/2018 3:35:16 AM Taisho Offers To Purchase Bristol-Myers Squibb’s UPSA Consumer Health Business For $1.6 Bln
12/17/2018 7:04:14 AM Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Sprycel For Pediatric Patients With Ph+ ALL
12/17/2018 7:00:54 AM Bristol-Myers Squibb, H3 Biomedicine Unveil Multi-year Research Collaborationm
12/10/2018 2:02:21 AM Bristol-Myers,Vedanta Announce Collaboration To Evaluate OPDIVO , VE800 In Patients With Advanced Or Metastatic Cancers
12/6/2018 4:18:04 PM Bristol-Myers Squibb Co. (BMY) Declares Quarterly Dividend of $ 0.41, Record Date 1/4/2019
12/6/2018 4:16:46 PM Bristol-Myers Squibb Declares Quarterly Dividend Of $0.41, Payable Feb. 1/ Record Jan. 4
11/27/2018 7:15:14 AM William Blair Reiterates Bristol-Myers Squibb Co. (BMY) At Outperform
11/15/2018 4:32:30 PM Bristol-Myers Gets Positive CHMP Opinion Recommending Approval Of Opdivo Plus Low-Dose Yervoy